Journal of Multidisciplinary Applied Natural Science
##plugins.themes.gdThemes.journalSlogan##
Scopus CiteScore 2024
4.8
Calculated on 05 May, 2025
SJR 2024
0.31
Powered by scimagojr.com
##plugins.themes.gdThemes.journalSlogan##
4.8
Calculated on 05 May, 2025
0.31
Powered by scimagojr.com
https://doi.org/10.47352/jmans.2774-3047.344
Iksen Iksen
Fani Nuryana Manihuruk
Hariyadi Dharmawan Syahputra
Mazmuranda Saragih
Ivan Eben Ezer Manurung
Ruth Sari Uni Peranginangin
Dea Febrince Putri Saragih
Helen Anjelina Simanjuntak
Kasta Gurning
Garcinia atroviridis (GA) is widely used in Southeast Asia, but its anticancer potential is less studied than that of other Garcinia species. This work aimed to investigate the flavonoid constituents of GA and their molecular mechanisms against lung cancer using an integrated systems pharmacology and experimental approach. Phytochemical profiling was performed by LC–HRMS, and flavonoid-associated targets were predicted using SwissTargetPrediction. Lung cancer–related genes were collected from GSE19188 and GeneCards, with overlapping targets identified through Venn analysis. Protein–protein interaction (PPI) analysis defined hub genes, while molecular docking and dynamics simulations assessed ligand–target interactions. Finally, cytotoxicity of the GA ethanolic extract was evaluated in A549, H460, and BEAS-2B cells after 72 h treatment. Our investigation revealed the presence of 5 major flavonoids, including icariin. Network analysis revealed 142 overlapping targets, with SRC, HSP90AA1, CTNNB1, PIK3R1, and AKT1 emerging as hubs. Docking showed strong binding affinities, particularly between quercetin-3β-D-glucoside and SRC, which was confirmed by stable molecular dynamics simulations. In vitro, GA extract reduced the viability of A549 and H460 cells with lower IC₅₀ values than in BEAS-2B. GA exerts selective anticancer effects against lung cancer primarily through targeting SRC, with supportive modulation of HSP90AA1, CTNNB1, PIK3R1, and AKT1. These findings position SRC as the key mechanistic anchor and highlight GA as a promising source for multi-targeted cancer therapy.
[1] C. Li, S. Lei, L. Ding, Y. Xu, X. Wu, H. Wang, Z. Zhang, T. Gao, Y. Zhang, and L. Li. (2023). "Global burden and trends of lung cancer incidence and mortality". Chinese Medical Journal. 136 (13): 1583-1590. 10.1097/CM9.0000000000002529.
DOI: https://doi.org/10.1097/CM9.0000000000002529[2] U. Anand, A. Dey, A. K. S. Chandel, R. Sanyal, A. Mishra, D. K. Pandey, V. De Falco, A. Upadhyay, R. Kandimalla, A. Chaudhary, J. K. Dhanjal, S. Dewanjee, J. Vallamkondu, and J. M. Pérez de la Lastra. (2023). "Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics". Genes & Diseases. 10 (4): 1367-1401. 10.1016/j.gendis.2022.02.007.
DOI: https://doi.org/10.1016/j.gendis.2022.02.007[3] Iksen, P. Pothongsrisit, and V. Pongrakhananon. (2021). "Targeting the PI3K/AKT/mTOR signaling pathway in lung cancer: An update regarding potential drugs and natural products". Molecules. 26 (13): 4100. 10.3390/molecules26134100.
DOI: https://doi.org/10.3390/molecules26134100[4] N. Muhammad, D. Usmani, M. Tarique, H. Naz, M. Ashraf, R. Raliya, S. Tabrez, T. A. Zughaibi, A. Alsaieedi, I. J. Hakeem, and M. Suhail. (2022). "The role of natural products and their multitargeted approaches in treating solid cancer". Cells. 11 (14): 2209. 10.3390/cells11142209.
DOI: https://doi.org/10.3390/cells11142209[5] P. Chunarkar-Patil, M. Kaleem, R. Mishra, S. Ray, A. Ahmad, D. Verma, S. Bhayye, R. Dubey, H. N. Singh, and S. Kumar. (2024). "Anticancer drug discovery based on natural products: From computational approaches to clinical studies". Biomedicines. 12 (1): 201. 10.3390/biomedicines12010201.
DOI: https://doi.org/10.3390/biomedicines12010201[6] A. N. Panche, A. D. Diwan, and S. R. Chandra. (2016). "Flavonoids: An overview". Journal of Nutritional Science. 5 : e47. 10.1017/jns.2016.41.
DOI: https://doi.org/10.1017/jns.2016.41[7] A. Ullah, S. Munir, S. L. Badshah, N. Khan, L. Ghani, B. G. Poulson, A. H. Emwas, and M. Jaremko. (2020). "Important flavonoids and their role as a therapeutic agent". Molecules. 25 (22): 5243. 10.3390/molecules25225243.
DOI: https://doi.org/10.3390/molecules25225243[8] P. Wan, X. Li, S. Guo, and X. Zhao. (2024). "Combination effect of flavonoids attenuates lung cancer cell proliferation by inhibiting the STAT3 and FAK signaling pathway". Open Life Sciences. 19 : 20220977. 10.1515/biol-2022-0977.
DOI: https://doi.org/10.1515/biol-2022-0977[9] M. Shahid, D. Law, A. Azfaralariff, M. M. Mackeen, T. F. Chong, and S. Fazry. (2022). "Phytochemicals and biological activities of Garcinia atroviridis: A critical review". Toxics. 10 (11): 656. 10.3390/toxics10110656.
DOI: https://doi.org/10.3390/toxics10110656[10] B. L. S. do Espírito Santo, L. F. Santana, W. H. Kato Junior, F. d. O. de Araújo, D. Bogo, K. d. C. Freitas, R. d. C. A. Guimarães, P. A. Hiane, A. Pott, W. F. d. O. Filiú, M. Arakaki Asato, P. d. O. Figueiredo, and P. R. H. d. O. Bastos. (2020). "Medicinal potential of Garcinia species and their compounds". Molecules. 25 (19): 4513. 10.3390/molecules25194513.
DOI: https://doi.org/10.3390/molecules25194513[11] D. Obolskiy, I. Pischel, N. Siriwatanametanon, and M. Heinrich. (2009). "Garcinia mangostana L.: A phytochemical and pharmacological review". Phytotherapy Research. 23 (8): 1047-1065. 10.1002/ptr.2730.
DOI: https://doi.org/10.1002/ptr.2730[12] J. Tang and T. Aittokallio. (2014). "Network pharmacology strategies toward multi-target anticancer therapies: From computational models to experimental design principles". Current Pharmaceutical Design. 20 (1): 23-36. 10.2174/13816128113199990470.
DOI: https://doi.org/10.2174/13816128113199990470[13] C. P. Joshi, A. Baldi, N. Kumar, and J. Pradhan. (2025). "Harnessing network pharmacology in drug discovery: An integrated approach". Naunyn-Schmiedeberg’s Archives of Pharmacology. 398 (5): 4689-4703. 10.1007/s00210-024-03625-3.
DOI: https://doi.org/10.1007/s00210-024-03625-3[14] Iksen, N. Singharajkomron, H. M. Nguyen, H. N. T. Hoang, D. V. Ho, and V. Pongrakhananon. (2024). "Adunctin E from Conamomum rubidum induces apoptosis in lung cancer via HSP90AA1 modulation: A network pharmacology and in vitro study". International Journal of Molecular Sciences. 25 (21): 11368. 10.3390/ijms252111368.
DOI: https://doi.org/10.3390/ijms252111368[15] Iksen, S. Sinsook, O. Wattanathamsan, K. Buaban, S. Chamni, and V. Pongrakhananon. (2022). "Target identification of 22-(4-pyridinecarbonyl) jorunnamycin A from Xestospongia sp. in mediating non-small-cell lung cancer cell apoptosis". Molecules. 27 (24): 8948. 10.3390/molecules27248948.
DOI: https://doi.org/10.3390/molecules27248948[16] G. Stelzer, N. Rosen, I. Plaschkes, S. Zimmerman, M. Twik, S. Fishilevich, T. Iny Stein, R. Nudel, I. Lieder, Y. Mazor, S. Kaplan, D. Dahary, D. Warshawsky, Y. Guan-Golan, A. Kohn, N. Rappaport, M. Safran, and D. Lancet. (2016). "The GeneCards suite: From gene data mining to disease genome sequence analyses". Current Protocols in Bioinformatics. 54 : 1.30.1-1.30.33. 10.1002/cpbi.5.
DOI: https://doi.org/10.1002/cpbi.5[17] A. Daina, O. Michielin, and V. Zoete. (2019). "SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules". Nucleic Acids Research. 47 (W1): W357-W364. 10.1093/nar/gkz382.
DOI: https://doi.org/10.1093/nar/gkz382[18] H. D. Syahputra, M. Masfria, P. A. Z. Hasibuan, and Iksen. (2022). "In silico docking studies of phytosterol compounds from Ficus religiosa as potential chemopreventive agents". Rasayan Journal of Chemistry. 15 (2): 1080-1084. 10.31788/RJC.2022.1526801.
DOI: https://doi.org/10.31788/RJC.2022.1526801[19] A. Tedasen, A. Chiabchalard, T. Tencomnao, K. Yamasaki, H. J. Majima, A. Phongphithakchai, and M. Chatatikun. (2024). "Anti-melanogenic activity of ethanolic extract from Garcinia atroviridis fruits using in vitro experiments, network pharmacology, molecular docking, and molecular dynamics simulation". Antioxidants. 13 (6). 10.3390/antiox13060713.
DOI: https://doi.org/10.3390/antiox13060713[20] W. N. Tan, M. Khairuddean, K. C. Wong, W. Y. Tong, and D. Ibrahim. (2016). "Antioxidant compounds from the stem bark of Garcinia atroviridis". Journal of Asian Natural Products Research. 18 (8): 804-811. 10.1080/10286020.2016.1160071.
DOI: https://doi.org/10.1080/10286020.2016.1160071[21] J. H. Han, K. W. Jang, and C. S. Myung. (2022). "Garcinia cambogia attenuates adipogenesis by affecting CEBPB and SQSTM1/p62-mediated selective autophagic degradation of KLF3 through RPS6KA1 and STAT3 suppression". Autophagy. 18 (3): 518-539. 10.1080/15548627.2021.1936356.
DOI: https://doi.org/10.1080/15548627.2021.1936356[22] F. Lin, M. J. J. Recchia, T. N. Clark, E. J. Kennelly, R. G. Linington, and C. Long. (2025). "Metabolite profiling and characterization of potential anticancer constituents from Garcinia subfalcata using UPLC-IMS-QTOF-MS". Food Chemistry. 465 : 141900. 10.1016/j.foodchem.2024.141900.
DOI: https://doi.org/10.1016/j.foodchem.2024.141900[23] S. Zhang, K. Liu, Y. Liu, X. Hu, and X. Gu. (2025). "The role and application of bioinformatics techniques and tools in drug discovery". Frontiers in Pharmacology. 16 : 1547131. 10.3389/fphar.2025.1547131.
DOI: https://doi.org/10.3389/fphar.2025.1547131[24] A. L. Hopkins. (2008). "Network pharmacology: The next paradigm in drug discovery". Nature Chemical Biology. 4 (11): 682-690. 10.1038/nchembio.118.
DOI: https://doi.org/10.1038/nchembio.118[25] Y.-H. Lai, M.-H. Chen, S.-Y. Lin, S.-Y. Lin, Y.-H. Wong, S.-L. Yu, H.-W. Chen, C.-H. Yang, G.-C. Chang, and J. J. W. Chen. (2015). "Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways". Oncotarget. 6 (28): 26252-26265. 10.18632/oncotarget.4761.
DOI: https://doi.org/10.18632/oncotarget.4761[26] S. Xuetong, G. Chundi, L. Huayao, L. Cun, W. Longyun, L. Ye, L. Ruijuan, S. Changgang, and Z. Jing. (2023). "Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer". Frontiers in Pharmacology. 14 : 1250893. 10.3389/fphar.2023.1250893.
DOI: https://doi.org/10.3389/fphar.2023.1250893[27] W. Zhu, H. Wang, and D. Zhu. (2022). "Wnt/β-catenin signaling pathway in lung cancer". Medicine in Drug Discovery. 13 : 100113. 10.1016/j.medidd.2021.100113.
DOI: https://doi.org/10.1016/j.medidd.2021.100113[28] M. Niu, B. Zhang, L. Li, Z. Su, W. Pu, C. Zhao, L. Wei, P. Lian, R. Lu, R. Wang, J. Wazir, Q. Gao, S. Song, and H. Wang. (2021). "Targeting HSP90 inhibits proliferation and induces apoptosis through the AKT1/ERK pathway in lung cancer". Frontiers in Pharmacology. 12 : 724192. 10.3389/fphar.2021.724192.
DOI: https://doi.org/10.3389/fphar.2021.724192[29] Z. Zhao, B. Liu, J. Sun, L. Lu, L. Liu, J. Qiu, Q. Li, C. Yan, S. Jiang, N. Mohammadtursun, W. Ma, M. Li, J. Dong, and W. Gong. (2019). "Scutellaria flavonoids effectively inhibit the malignant phenotypes of non-small cell lung cancer in an Id1-dependent manner". International Journal of Biological Sciences. 15 (7): 1500-1513. 10.7150/ijbs.33146.
DOI: https://doi.org/10.7150/ijbs.33146[30] S. Martellucci, L. Clementi, S. Sabetta, V. Mattei, L. Botta, and A. Angelucci. (2020). "Src family kinases as therapeutic targets in advanced solid tumors: What we have learned so far". Cancers. 12 (6): 1448. 10.3390/cancers12061448.
DOI: https://doi.org/10.3390/cancers12061448[31] H. Zou, J. Luo, Y. Guo, T. Tong, Y. Liu, Y. Chen, Y. Xiao, L. Ye, C. Zhu, L. Deng, B. Wang, Y. Pan, and P. Li. (2023). "Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer". Cellular and Molecular Life Sciences. 80 (2): 41. 10.1007/s00018-023-04688-w.
DOI: https://doi.org/10.1007/s00018-023-04688-w[32] P. He, W. Wu, H. Wang, K. Liao, W. Zhang, G. Xiong, F. Wu, G. Meng, and K. Yang. (2013). "Co-expression of Rho guanine nucleotide exchange factor 5 and Src associates with poor prognosis of patients with resected non-small cell lung cancer". Oncology Reports. 30 (6): 2864-2870. 10.3892/or.2013.2797.
DOI: https://doi.org/10.3892/or.2013.2797[33] L. Huang, Y. Lu, L. Yi, Y. Zhao, T. Si, and M. Zhang. (2025). "Exploring the potential value of SRC in pan cancer based on bioinformatics methods". Discover Oncology. 16 (1): 1309. 10.1007/s12672-025-02402-9.
DOI: https://doi.org/10.1007/s12672-025-02402-9[34] B. Rubio-Cuesta, C. Carretero-Puche, P. Llamas, J. Sarmentero, B. Gil-Calderon, A. Lens-Pardo, B. Antón-Pascual, E. Rubio-González, M. Cámara-Jurado, J. Salamanca, D. Rueda-Fernández, M. D. Delcuratolo, B. Soldevilla, and R. Garcia-Carbonero. (2025). "Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer". British Journal of Cancer. 133 (3): 404-419. 10.1038/s41416-025-03058-6.
DOI: https://doi.org/10.1038/s41416-025-03058-6[35] S. T. Asma, U. Acaroz, K. Imre, A. Morar, S. R. A. Shah, S. Z. Hussain, D. Arslan-Acaroz, H. Demirbas, Z. Hajrulai-Musliu, F. R. Istanbullugil, A. Soleimanzadeh, D. Morozov, K. Zhu, V. Herman, A. Ayad, C. Athanassiou, and S. Ince. (2022). "Natural products/bioactive compounds as a source of anticancer drugs". Cancers. 14 (24): 6203. 10.3390/cancers14246203.
DOI: https://doi.org/10.3390/cancers14246203[36] X. Wu, W. Kong, X. Qi, S. Wang, Y. Chen, Z. Zhao, W. Wang, X. Lin, J. Lai, Z. Yu, and G. Lai. (2019). "Icariin induces apoptosis of human lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway". Life Sciences. 239 : 116879. 10.1016/j.lfs.2019.116879.
DOI: https://doi.org/10.1016/j.lfs.2019.116879[37] J.-L. Wang, Q. Quan, R. Ji, X.-Y. Guo, J.-M. Zhang, X. Li, and Y.-G. Liu. (2018). "Isorhamnetin suppresses PANC-1 pancreatic cancer cell proliferation through S phase arrest". Biomedicine & Pharmacotherapy. 108 : 925-933. 10.1016/j.biopha.2018.09.105.
DOI: https://doi.org/10.1016/j.biopha.2018.09.105[38] J. H. Chang. (2017). "Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways". Biochimica et Biophysica Acta - Molecular Cell Research. 1864 (10): 1746-1758. 10.1016/j.bbamcr.2017.06.017.
DOI: https://doi.org/10.1016/j.bbamcr.2017.06.017